Gene Variant Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Gene FGFR1
Variant D128V
Impact List missense
Protein Effect unknown
Gene Variant Descriptions FGFR1 D128V lies within the extracellular domain of the Fgfr1 protein (UniProt.org). D128V results in altered proliferation relative to wild-type Fgfr1 in a competition assay, but results in transformation activity similar to wild-type Fgfr1 in cultured cells (PMID: 34272467), and therefore, its effect on Fgfr1 protein function is unknown.
Associated Drug Resistance
Category Variants Paths

FGFR1 mutant FGFR1 D128V

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Transcript NM_023110.3
gDNA chr8:g.38428411T>A
cDNA c.383A>T
Protein p.D128V
Source Database RefSeq
Genome Build GRCh38/hg38
Transcript gDNA cDNA Protein Source Database Genome Build
XM_011544446.3 chr8:g.38429756T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_001354369.1 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_015850.3 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_001174063.2 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_017013219.2 chr8:g.38429756T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_006716307.2 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_011544444.2 chr8:g.38429756T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_011544445.3 chr8:g.38429756T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_001174063.1 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_006716304.1 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_017013224.2 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_006716303.4 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_017013220.2 chr8:g.38429756T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_001410922.1 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_015850.4 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_017013231.2 chr8:g.38429756T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_017013221.2 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_001174065.1 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_006716307.1 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_001174065.2 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_017013225.3 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_001354369.2 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_023110.3 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_006716304.2 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_017013225.2 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_011544447.3 chr8:g.38429756T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_023110.2 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_011544452.3 chr8:g.38429756T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_001354367.1 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_047421569.1 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_017013222.2 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_047421575.1 chr8:g.38429756T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_006716303.3 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_001174067.2 chr8:g.38429756T>A c.383A>T p.D128V RefSeq GRCh38/hg38
NM_001354367.2 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_047421570.1 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38
XM_017013221.1 chr8:g.38428411T>A c.383A>T p.D128V RefSeq GRCh38/hg38

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References
FGFR1 D128V Advanced Solid Tumor predicted - sensitive Pemigatinib Preclinical - Cell culture Actionable In a preclinical study, cells expressing FGFR1 D128V were sensitive to treatment with Pemazyre (pemigatinib) in culture, demonstrating reduced cell viability (PMID: 34272467). 34272467
FGFR1 D128V Advanced Solid Tumor predicted - sensitive Futibatinib Preclinical - Cell culture Actionable In a preclinical study, cells expressing FGFR1 D128V were sensitive to treatment with Lytgobi (futibatinib) in culture, demonstrating reduced cell viability (PMID: 34272467). 34272467
FGFR1 D128V Advanced Solid Tumor predicted - sensitive Erdafitinib Preclinical - Cell culture Actionable In a preclinical study, cells expressing FGFR1 D128V were sensitive to treatment with Balversa (erdafitinib) in culture, demonstrating reduced cell viability (PMID: 34272467). 34272467
FGFR1 D128V Advanced Solid Tumor predicted - sensitive E7090 Preclinical - Cell culture Actionable In a preclinical study, cells expressing FGFR1 D128V were sensitive to treatment with E7090 in culture, demonstrating reduced cell viability (PMID: 34272467). 34272467
FGFR1 D128V Advanced Solid Tumor predicted - sensitive Infigratinib Preclinical - Cell culture Actionable In a preclinical study, cells expressing FGFR1 D128V were sensitive to treatment with Truseltiq (infigratinib) in culture, demonstrating reduced cell viability (PMID: 34272467). 34272467
FGFR1 D128V Advanced Solid Tumor predicted - sensitive AZD4547 Preclinical - Cell culture Actionable In a preclinical study, cells expressing FGFR1 D128V were sensitive to treatment with AZD4547 in culture, demonstrating reduced cell viability (PMID: 34272467). 34272467